Valuation: Astal Laboratories Limited

Market Cap 2.76B 29.18M 25.54M 23.58M 21.99M 41.44M 42.18M 283M 110M 1.36B 110M 107M 4.74B P/E 2024
26.3x
P/E 2025 9.45x
Enterprise Value 2.87B 30.4M 26.61M 24.57M 22.91M 43.17M 43.95M 295M 114M 1.42B 114M 112M 4.94B EV / Sales 2024
1.45x
EV / Sales 2025 1.36x
Free-Float
38.01%
Yield 2024 *
-
Yield 2025 -
1 day+1.58%
1 week+14.80%
1 month+20.46%
3 months+36.11%
6 months+2.43%
Current year+2.43%
1 week 79
Extreme 79
91.3
1 month 65.45
Extreme 65.45
91.3
Current year 60.45
Extreme 60.45
91.9
1 year 60.45
Extreme 60.45
103.2
3 years 22.41
Extreme 22.41
131.7
5 years 5.41
Extreme 5.41
131.7
10 years 5.41
Extreme 5.41
131.7
Manager TitleAgeSince
Director of Finance/CFO 51 2023-07-14
Compliance Officer 32 2023-04-18
Director TitleAgeSince
Director/Board Member 55 2023-08-17
Director/Board Member 62 -
Director/Board Member - 2022-09-07
Change 5-day change 1-year change 3-year change Capi.($)
+1.58%+14.80%+11.14%+192.44% 40.47M
-2.48%+8.34%+53.87%+155.75% 1,097B
-1.76%+6.23%+66.27%+53.44% 622B
-1.05%+7.19%+35.57%+86.77% 449B
+0.83%+4.18%+31.11%+23.88% 334B
-1.38%+3.75%+39.33%+25.04% 294B
+0.30%+2.56%+31.62%+40.64% 286B
-0.10%+2.23%-28.43%-42.77% 213B
+0.44%+4.35%+29.69%+63.10% 195B
+0.01%+1.03%+13.95%+63.93% 157B
Average -0.33%+5.90%+28.41%+66.22% 364.68B
Weighted average by Cap. -1.12%+7.04%+40.91%+77.66%

Financials

2024 2025
Net sales 237M 2.5M 2.19M 2.02M 1.89M 3.55M 3.62M 24.25M 9.42M 117M 9.4M 9.19M 407M 637M 6.73M 5.89M 5.44M 5.07M 9.56M 9.73M 65.25M 25.33M 314M 25.29M 24.73M 1.09B
Net income 7.85M 82.99K 72.64K 67.06K 62.55K 118K 120K 804K 312K 3.87M 312K 305K 13.49M 89.25M 944K 826K 763K 711K 1.34M 1.36M 9.15M 3.55M 44.04M 3.55M 3.47M 153M
Net Debt -57.64M -610K -534K -493K -459K -866K -881K -5.91M -2.29M -28.44M -2.29M -2.24M -99.09M 115M 1.22M 1.07M 986K 920K 1.73M 1.76M 11.83M 4.59M 56.94M 4.58M 4.48M 198M
Logo Astal Laboratories Limited
Astal Laboratories Limited is an India-based company, which is engaged in the manufacturing and sale of pharmaceutical intermediates and bulk drugs. The Company is engaged in manufacturing fine chemicals, specialty chemicals and pharmaceutical intermediates. The Company’s products include HF Acid (2-Chloro-1,3-Bis (Dimethylamino) Trimethinium Hexafluorophosphate); 4-Methyl Sulphonyl Phenyl Acetic acid, (1R,3R)-methyl 1-(benzo[d][1,3] dioxol-5-yl)- 2,3,4,9-tetrahydro-1 H-pyrido[3,4-b]indole-3- carboxylate hydrochloride; L-Valine methyl ester Hydrochloride (LVMH); L-Valine benzyl ester Hydrochloride; N-[(2-Cyanobiphenyl-4-methyl)- L-Valine methyl ester Hydrochloride; D-Tryptophan Methyl Ester Hydrochloride; Moc-L-valine (N-(Methoxycarbonyl)-L-valine); 2-Ethoxyethyl-4-methylbenzene sulfonate; 2 Piperidin-4-yl-1H-benzoimidazole; Alpha, alpha-Dimethyl Phenyl Acetic Acid (2-Methyl-2-phenylpropionic acid); 2-(4-bromophenyl)-2-methylpropionic acid; Methyl 2,2-dimethylphenylacetate, and others.
Employees
-
Date Price Change Volume
26-06-30 ₹88.96 +1.58% 33,637
26-06-29 ₹87.58 -0.69% 115,777
26-06-25 ₹88.19 +12.92% 137,452
26-06-24 ₹78.10 +0.79% 9,030
26-06-23 ₹77.49 -3.98% 24,763
  1. Stock Market
  2. Stocks
  3. 512600 Stock